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Introduction:

Underlying Pathophysiology:

Ebola is a hemorrhagic disease
that has been seen throughout Liberia,
but because of international travel it is
spreading. Gilsdorf, Morgan and
Leitmeyer (2012) researched air travel
and reported that, “In 2010, 5.04 billion
passengers arrived and departed from
1318 airports worldwide… and travel to
and from Africa almost doubled
between 1995 and 2005.” (p.1471). In
the last few months there have been
cases of Ebola reported in Spain and the
United States linked to travel.
These are recent developments
because as of July, 2014 the Center for
Disease Control and Prevention (CDC)
reported “to date there are no cases
reported in the United States.” (CDC,
2014). Turner (2014) reports that “the
incubation period can be as long as 21
days.” (p.68) This gives exposed people
a chance to travel to any place in the
world and expose others to this
potentially fatal virus. The public that
flies in planes may have a risk, but the
people that are at greater risk are
healthcare workers that care for Ebola
patients.

Ebola virus usually infects humans through openings in the skin or mucous membranes.
Antigen-presenting cells such as macrophages and dendrite cells (DCs) located at the site
of infection, are primary targets of Ebola replication…the cells become functionally
deregulated and are unable to express co-stimulatory molecules or stimulate
lymphocytes, namely naïve T cells. Unresponsiveness of DCs to Ebola infection most
likely contributes to the massive lymphocyte apoptosis routinely observed in clinical
cases of infection in humans. Ebola infection of monocytes and macrophages elicits the
release of massive amounts of pro-inflammatory cytokines and chemokines. This
“cytokines storm” recruits additional antigen-presenting cells (APCs) to the site of
infection, increasing the number of host to support virus replication. It also contributes
to the pathogenesis at the late stage of disease by increasing endothelial permeability
and vascular leakage which, in turn, foster rapid dissemination of infected APCs
throughout the systemic circulation to release Ebola in the secondary lymphoid organs,
lungs, liver and other ancillary sites of virus replication. (Choi & Croyle, 2013, p.566).
More information on lymphocytes:
Limited data from patients and more extensive data from laboratory animals indicate
that massive lymphocyte apoptosis occurs during Ebola hemorrhagic fever and may
contribute to the high death rate. Thus, the few patients who survive infection develop
antibodies to the virus during the second week of illness, while fatally infected persons
apparently undergo terminal immunosuppression similar to that with septic
shock.(Parrino, Hotchkiss,& Bray, 2007,p.194).
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Significance of Pathophysiology:

Pathophysiological Processes:
When researching Ebola it was revealed that infected individuals have been
known to fly to other countries while infected, but the risk to fellow travelers is not
very high. Gilsdorf, Morgan and Leitmeyer (2012) reviewed a few cases of people
traveling internationally with Ebola “…the reviewed studies show a low risk of
transmission in the early phase of symptomatic patients, even if high risk exposure
occurred.” (p.1471). It seems that high risk exposure is “direct physical contact.”
(p.1472). They go on to say, “ In the outbreak in 2000 in Uganda the most important
risk factor was direct and repeated contact with a sick person’s body fluids, as occurs
during the provision of care.” (Gilsdorf, Morgan, & Leitmeyer, 2012, p.1472). This
would indicate that the persons providing care over time is at greater risk and current
events have proved this to be true. The infected persons in Spain and the United
States are both healthcare providers. Even though the infected person traveled a great
distance and came in contact with many people along the way, it was a nurse with
personal protective devices (PPE) in both cases that was stricken.

Signs and Symptoms:
Ebola virus disease is, “characterized by a sudden onset of fever, intense
weakness, headache, and sore throat,” reports WHO. (WHO, 2014). The CDC says the
fever is, “greater than 101.5 Fahrenheit.” Additional symptoms are “vomiting,
diarrhea and unexplained hemorrhage.” (CDC, 2014). Laboratory findings “include
low white blood cell and platelet counts and elevated liver enzymes.” (WHO, 2014).
The CDC says screen for temps “greater than 101.5
Fahrenheit.”
Intense weakness
vomiting
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Implication for Nursing Care:
Ebola will change nursing care now and in the future. A patient with
a temperature will have to be questioned about recent travel and contacts.
Park says, “First asking the patient about where they have been in the past
month to triage those who are at highest risk of having Ebola, and also
having a room ready for those who they suspect might be infected.” (Park,
2014, p.2). Although, it is reported that these patients can be taken care of in
any hospital, this may be a return of isolation rooms or wards.
The CDC put out recommendations for hospitals caring for Ebola
patients and those recommendations include, single patient rooms with an
entry log, all personnel entering must wear gloves, fluid resistant gowns,
eye protection and a face mask (PPE). If the patient is vomiting or bleeding
double gloving, shoe covers and leg covering is recommended. Sharps must
be handled with extreme care. If a healthcare worker is exposed to a patient
without PPE they need to be monitored twice daily after the exposure.
(CDC, 2014).
In the case of death, “Handling of the remains should be kept at a
minimum.” (CDC, 2014).The PPE listed above is used after death as well.
The CDC reports that at the “site of death, the body should be wrapped in a
plastic shroud. Intravenous lines and endotracheal tubes are left in place.
The body is double bagged in a leak proof plastic bag. This is an unfortunate
part of hospital personal now that Ebola is here.

Lastly, overproduction of pro-coagulant tissue factors is
being explored. This is done by stimulating coagulation by
giving factor VIIa or activating the natural anticoagulant
protein C pathway, thus decreasing production of proinflammatory cytokines. These along with other ways are
being tested to save Ebola infected people. (Choi &
Croyle,2013, p. 571).
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The pathophysiology of Ebola may be the answer for a vaccine or
serum to stop the virus. Choi and Croyle (2013) report that many vaccine
paths have been followed, trying to find a perfect result. They first used
“Ebola proteins” but these were found to “override pre-existing
immunity…[this]is not desirable, since high doses of adenovirus particles
can participate severe, toxic inflammatory responses in humans.” ( p.568).
Another vaccine approach is to give a live recombinant virus. This
protected small rodents, but when the virus was gamma-irradiated it lost its
ability to protect those same animals. (Choi & Croyle, 2013, p. 568). So
other methods are also being looked at.
Virus entry is an essential step in the virus life
cycle and is often an attractive target for therapy,
since inhibition of this process blocks replication
at an early stage, significantly reducing the
chance for the virus to evolve and develop drug
resistance. (Choi& Croyle, 2007, p.571).
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Conclusion:
A few months ago, Ebola was an African virus that Americans
did not need to worry about, how quickly things change. America has
had an Ebola patient die after traveling to a Texas hospital. A nurse
infected, is fighting for her life after contact with this man. Many
people are being isolated that were on the plane, in the airport or
homes were he went. These all seem like innocent everyday
activities.
Nurses are at a high risk to come in contact with Ebola
patients’ body fluids without effective PPEs in place. This virus is
going to affect many nurses. It may be positive or negative, time will
tell.
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